Related Experiment Video
Updated: May 27, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
Published on: January 17, 2025
Recurrent infections and immune evasion strategies of Staphylococcus aureus
Hwan Keun Kim1, Vilasack Thammavongsa, Olaf Schneewind
1Department of Microbiology, University of Chicago, Chicago, IL 60637, United States.
Abstract:
Staphylococcus aureus causes purulent skin and soft tissue infections (SSTIs) that frequently reoccur. Staphylococal SSTIs can lead to invasive disease and sepsis, which are among the most significant causes of infectious disease mortality in both developed and developing countries. Human or animal infections with S. aureus do not elicit protective immunity against staphylococcal diseases. Here we review what is known about the immune evasive strategies of S. aureus that enable the pathogen's escape from protective immune responses. Three secreted products are discussed in detail, staphylococcal protein A (SpA), staphylococcal binder of immunoglobulin (Sbi) and adenosine synthase A (AdsA). By forming a complex with V(H)3-type IgM on the surface of B cells, SpA functions as a superantigen to modulate antibody responses to staphylococcal infection. SpA also captures pathogen-specific antibodies by binding their Fcγ portion. The latter activity of SpA is shared by Sbi, which also associates with complement factors 3d and factor H to promote the depletion of complement. AdsA synthesizes the immune signaling molecule adenosine, thereby dampening innate and adaptive immune responses during infection. We discuss strategies how the three secreted products of staphylococci may be exploited for the development of vaccines and therapeutics.
Insights
Staphylococcus aureus evades the immune system using secreted proteins like SpA, Sbi, and AdsA. Understanding these immune evasion strategies is key to developing effective vaccines and treatments for staphylococcal infections.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Staphylococcus aureus causes recurrent skin and soft tissue infections (SSTIs), leading to invasive disease and sepsis.
- Staphylococcal infections do not induce protective immunity, posing a significant global health challenge.
- Effective treatments are limited due to the pathogen's ability to evade immune responses.
Purpose of the Study:
- To review the immune evasive strategies employed by Staphylococcus aureus.
- To detail the roles of three key secreted products: staphylococcal protein A (SpA), staphylococcal binder of immunoglobulin (Sbi), and adenosine synthase A (AdsA).
- To explore potential therapeutic and vaccine development avenues based on these evasion mechanisms.
Main Methods:
- Review of existing literature on Staphylococcus aureus virulence factors and immune evasion.
- Detailed analysis of the molecular mechanisms of SpA, Sbi, and AdsA in subverting host immunity.
- Discussion of potential applications for vaccine and therapeutic strategies.
Main Results:
- SpA modulates antibody responses by acting as a superantigen and binding pathogen-specific antibodies.
- Sbi binds complement factors, promoting complement system depletion.
- AdsA synthesizes adenosine, suppressing innate and adaptive immune responses.
Conclusions:
- SpA, Sbi, and AdsA are critical secreted factors enabling Staphylococcus aureus immune evasion.
- Targeting these secreted products offers promising strategies for novel vaccines and therapeutics.
- Further research into these mechanisms can lead to improved control of staphylococcal infections.
Related Concept Videos
Staphylococcal Skin Infections
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Colonisation of Pathogens
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance

